HMGB1 and ovarian cancer: GA also presented anti-proliferative effects in leukemia [24] and human ovarian cancer cell lines [25], and was shown to target prostate cancer cells via an anti-inflammatory pathway through downregulation of HMGB1, IL-6 and IL-8 [26].